Paul Navarre Joins LEO Pharma’s Board of Directors

Mr. Navarre currently serves as chairman of the Board of Directors at HTL and Arkopharma, as Vice Chairman of Hallura, and as Strategic Advisor to other companies.

Paul Navarre is the newest member of LEO Pharma’s Board of Directors.

Mr. Navarre currently serves as chairman of the Board of Directors at HTL (dermatology) and Arkopharma (Dietary Supplements), as Vice Chairman of Hallura (dermatology) and as Strategic Advisor to other companies. From 2017-2020, he held the position as CEO of Ferring US Holding subsequent to ten years at Allergan, among other as President of International Operations (global except US) and President of EAME (Europe, Middle East and Africa). Prior to that, he spent 15 years at Procter & Gamble managing multiple countries and global brands in pharmaceuticals and Health and beauty care.

“With his impressive career, Paul brings extensive strategic and commercial experience from the global biotech and dermatology market, that will be of great value to LEO Pharma in its ambitions to create future growth and become a top five company within medical dermatology. I am excited to be working together with Paul going forward”, says Jesper Brandgaard, chairman of the Board of Directors at LEO Pharma, in a news release.

“It’s a privilege to join the Board of Directors at LEO Pharma at this time in the company’s history. With its ongoing transformation, many steps have already been taken to position the company for future growth and I look much forward to being part of continuing this development,” says Mr.  Navarre.